Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61c0b38c0948cdbce0b193c5279ab4a9 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404 |
filingDate |
1995-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2001-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e62e643f592d01eab1423ec13b7e42d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09f94f4f610635890dbf2bd39d6f6209 |
publicationDate |
2001-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2213241-C |
titleOfInvention |
Indole derivative for the treatment of migraine |
abstract |
This invention relates to (R)-5- (Aminosulphonylmethyl)-3-(N-methylpyrrolidin-2-ylmethyl)-1H- indole of formula I and its pharmaceutically acceptable salts. This compound is particularly useful in treating disorders arising from deficient serotonergic neurotransmission, especially migraine. |
priorityDate |
1994-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |